4D Pharma PLC
LBPS
LBPS was delisted on the 24th of June, 2022.
7 hedge funds and large institutions have $1.87M invested in 4D Pharma PLC in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
12% less capital invested
Capital invested by funds: $2.12M → $1.87M (-$244K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
+$107K |
| 2 |
Morgan Stanley
New York
|
+$81.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$419 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
-$196K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.99K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RL
1
Ruffer LLP
London,
United Kingdom
| $1.07M | – | – | – |
|
|
KC
2
Kepos Capital
New York
| $545K | -$196K | -29,000 | -22% |
|
|
3
Morgan Stanley
New York
| $114K | +$81.4K | +12,041 | +138% |
|
|
SG
4
StoneX Group
New York
| $86.6K | +$107K | +15,896 | New |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| $43K | -$1.99K | -294 | -4% |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $8K | +$419 | +62 | +4% |
|
7
UBS Group
Zurich,
Switzerland
| $5K | – | – | – |
|
LBPS Hedge Fund Activity: Q4 2021 in Review
7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC (LBPS) for Q4 2021, worth a combined $1.87M — down 12% from $2.12M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LBPS positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was StoneX Group, opening a new position worth an estimated $107K. The largest seller was Kepos Capital, cutting an estimated $196K.
- 7 institutional investors held 4D Pharma PLC (LBPS) as of Q4 2021, up from 6 in Q3 2021.
- Funds reported $1.87M of 4D Pharma PLC stock for Q4 2021, down 12% quarter-over-quarter.
- 1 fund opened new 4D Pharma PLC positions in Q4 2021 and 0 closed out, a net change of +1 holder.
- The largest 4D Pharma PLC buyer in Q4 2021 was StoneX Group, an estimated $107K added.
- The largest 4D Pharma PLC seller in Q4 2021 was Kepos Capital, an estimated $196K sold.
Based on aggregated 13F filings for Q4 2021.